HumMR1, a highly specific humanized single chain antibody for targeting EGFRvIII

International Immunopharmacology

Volumn 18, Issue 2, 2014, Pages 304-310

  Safdari, Yaghoub ^a,b   Farajnia, Safar ^a   Asgharzadeh, Mohammad ^b   Omidfar, Kobra ^c   Khalili, Masoumeh ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

EGFRvIII; Humanization; Single chain antibody; Specificity

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 8; GLUTAMINE; GLYCINE; HUMMR 1 ANTIBODY; ISOLEUCINE; LEUCINE; LYSINE; PROLINE; SERINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAVY CHAIN; HUMAN; LIGHT CHAIN; MTT ASSAY; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; WESTERN BLOTTING;

EGFRVIII; HUMANIZATION; SINGLE CHAIN ANTIBODY; SPECIFICITY;

AMINO ACID SEQUENCE; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE ALIGNMENT; SINGLE-CHAIN ANTIBODIES;

EID: 84891771598     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.12.006     Document Type: Article

References (35)

1. I.A. Lorimer, A. Keppler-Hafkemeyer, R.A. Beers, C.N. Pegram, D.D. Bigner, and I. Pastan Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display Proc Natl Acad Sci U S A 93 25 Dec. 10 1996 14815 14820 (Pubitemid 26419052)
2. N. Nakayashiki, K. Yoshikawa, K. Nakamura, N. Hanai, K. Okamoto, and S. Okamoto et al. Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor Jpn J Cancer Res 91 10 Oct. 2000 1035 1043
3. D.K. Moscatello, M. Holgado-Madruga, A.K. Godwin, G. Ramirez, G. Gunn, and P.W. Zoltick et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors Cancer Res 55 23 Dec. 1 1995 5536 5539
4. A.B. Heimberger, R. Hlatky, D. Suki, D. Yang, J. Weinberg, and M. Gilbert et al. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients Clin Cancer Res 11 4 Feb. 15 2005 1462 1466 10.1158/1078-0432.CCR-04-1737 [doi: 11/4/1462 [pii]] (Pubitemid 40315227)
5. I. Okamoto, L.C. Kenyon, D.R. Emlet, T. Mori, J. Sasaki, and S. Hirosako et al. Expression of constitutively activated EGFRvIII in non-small cell lung cancer Cancer Sci 94 1 Jan. 2003 50 56 (Pubitemid 36575858)
6. P.A. Humphrey, A.J. Wong, B. Vogelstein, M.R. Zalutsky, G.N. Fuller, and G.E. Archer et al. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma Proc Natl Acad Sci U S A 87 11 Jun. 1990 4207 4211
7. C.T. Kuan, C.J. Reist, C.F. Foulon, I.A. Lorimer, G. Archer, and C.N. Pegram et al. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts Clin Cancer Res 5 6 Jun. 1999 1539 1549 (Pubitemid 29282963)
8. C.T. Kuan, C.J. Wikstrand, G. Archer, R. Beers, I. Pastan, and M.R. Zalutsky et al. Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv Int J Cancer 88 6 Dec. 15 2000 962 969 [doi: 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U [pii]]
9. S. Okamoto, K. Yoshikawa, Y. Obata, M. Shibuya, S. Aoki, and J. Yoshida et al. Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor Br J Cancer 73 11 Jun. 1996 1366 1372 (Pubitemid 26175669)
10. R.W. Schroff, K.A. Foon, S.M. Beatty, R.K. Oldham, and A.C. Morgan Jr. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy Cancer Res 45 2 Feb. 1985 879 885 (Pubitemid 15161095)
11. D.L. Shawler, R.M. Bartholomew, L.M. Smith, and R.O. Dillman Human immune response to multiple injections of murine monoclonal IgG J Immunol 135 2 Aug. 1985 1530 1535 (Pubitemid 16237070)
12. Y. Safdari, S. Farajnia, M. Asgharzadeh, and M. Khalili Antibody humanization methods - a review and update Biotechnol Genet Eng Rev 29 2 2013 175 186 10.1080/02648725.2013.801235
13. N.R. Gonzales, E.A. Padlan, Schuck P. De PR, J. Schlom, and S.V. Kashmiri SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity Mol Immunol 41 9 Jul. 2004 863 872 10.1016/j.molimm.2004.03.041 [S0161589004001592 [pii]] (Pubitemid 38903170)
14. T. Pelat, H. Bedouelle, A.R. Rees, S.J. Crennell, M.P. Lefranc, and P. Thullier Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering J Mol Biol 384 5 Dec. 31 2008 1400 1407 10.1016/j.jmb.2008.10.033 [doi: S0022-2836(08)01310-7 [pii]]
15. R. Robert, V.A. Streltsov, J. Newman, L.A. Pearce, K.L. Wark, and O. Dolezal Germline humanization of a murine Abeta antibody and crystal structure of the humanized recombinant Fab fragment Protein Sci 19 2 Feb. 2010 299 308 10.1002/pro.312
16. W.Y. Hwang, J.C. Almagro, T.N. Buss, P. Tan, and J. Foote Use of human germline genes in a CDR homology-based approach to antibody humanization Methods 36 1 May 2005 35 42 10.1016/j.ymeth.2005.01.004 [doi: S1046-2023(05)00014-9 [pii]] (Pubitemid 40558814)
17. C. Chothia, and A.M. Lesk Canonical structures for the hypervariable regions of immunoglobulins J Mol Biol 196 4 Aug. 20 1987 901 917 [doi: 0022-2836(87)90412-8 [pii]] (Pubitemid 17127946)
18. C. Chothia, A.M. Lesk, E. Gherardi, I.M. Tomlinson, G. Walter, and J.D. Marks et al. Structural repertoire of the human VH segments J Mol Biol 227 3 Oct. 5 1992 799 817 [doi: 0022-2836(92)90224-8 [pii]]
19. R.C. Landry, A.C. Klimowicz, S.J. Lavictoire, S. Borisova, D.T. Kottachchi, and I.A. Lorimer et al. Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII J Mol Biol 308 5 May 18 2001 883 893 10.1006/jmbi.2001.4628 [[doi];S0022-2836(01)94628-5 [pii]] (Pubitemid 32574366)
20. P. Gupta, S.Y. Han, M. Holgado-Madruga, S.S. Mitra, G. Li, and R.T. Nitta et al. Development of an EGFRvIII specific recombinant antibody BMC Biotechnol 10 2010 72 10.1186/1472-6750-10-72 [doi: 1472-6750-10-72 [pii]]
21. Y. Safdari, S. Farajnia, M. Asgharzadeh, S. Ahdi khosroshahi, K. Veisi, and V. Ahmadzadeh et al. Protein L: a robust enzyme-conjugated molecule for detection of humanized single chain antibodies Monoclon Antib Immunodiagn Immunother 32 6 2013 409 412
22. Y. Safdari, S. Farajnia, M. Asgharzadeh, M. Khalili, and H. Zarei Jaliani Affinity measurement of single chain antibodies: a mathematical method facilitated by statistical software SigmaPlot Monoclon Antib Immunodiagn Immunother 33 1 2014
23. F. Yamoutpour, V. Bodempudi, S.E. Park, W. Pan, M.J. Mauzy, and R.A. Kratzke et al. Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity Mol Cancer Ther 7 11 Nov. 2008 3586 3597 10.1158/1535-7163.MCT-08-0653 [doi: 7/11/3586[pii]]
24. X. Zhou, J. Qiu, Z. Wang, N. Huang, X. Li, and Q. Li et al. In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin J Cancer Res Clin Oncol 138 7 Jul. 2012 1081 1090 10.1007/s00432-012-1181-7
25. J.B. McIntyre, P. Bose, A.C. Klimowicz, N.T. Brockton, S. Petrillo, and W. Matthews et al. Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma PLoS One 7 2 2012 e31723 10.1371/journal.pone.0031723 [PONE-D-11-18439]
26. X. Zhang, A. Bommareddy, W. Chen, S. Khalifa, R.S. Kaushik, and H. Fahmy et al. Sarcophine-diol, a chemopreventive agent of skin cancer, inhibits cell growth and induces apoptosis through extrinsic pathway in human epidermoid carcinoma A431 cells Transl Oncol 2 1 Mar. 2009 21 30
27. M.L. Janmaat, F.A. Kruyt, J.A. Rodriguez, and G. Giaccone Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways Clin Cancer Res 9 6 Jun. 2003 2316 2326 (Pubitemid 36687658)
28. H. Jing, J. Wang, P. Yang, X. Ke, G. Xia, and B. Chen Magnetic Fe(3)O(4) nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells Int J Nanomedicine 5 2010 999 1004 10.2147/IJN.S14957
29. H.W. Jung, and S.H. Ghil A Torilis japonica extract exerts anti-proliferative activities on the U87MG human glioblastoma cell line Mol Med Rep 3 6 Nov. 2010 1041 1045 10.3892/mmr.2010.376
30. D. Patel, A. Lahiji, S. Patel, M. Franklin, X. Jimenez, and D.J. Hicklin et al. Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface Anticancer Res 27 5A Sep. 2007 3355 3366 (Pubitemid 47607562)
31. P. Tan, D.A. Mitchell, T.N. Buss, M.A. Holmes, C. Anasetti, and J. Foote "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28 J Immunol 169 2 Jul. 15 2002 1119 1125 (Pubitemid 34759912)
32. H.P. Taylor, and N.R. Cooper Human cytomegalovirus binding to fibroblasts is receptor mediated J Virol 63 9 Sep. 1989 3991 3998 (Pubitemid 19205475)
33. C.W. Laidley, and P. Thomas Partial characterization of a sex-steroid binding protein in the spotted seatrout (Cynoscion nebulosus) Biol Reprod 51 5 Nov. 1994 982 992 (Pubitemid 24313368)
34. L.T. Krebs, J.M. Hanesworth, M.F. Sardinia, R.C. Speth, J.W. Wright, and J.W. Harding A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme J Pharmacol Exp Ther 293 1 Apr. 2000 260 267 (Pubitemid 30180947)
35. Y.H. Xu, N. Richert, S. Ito, G.T. Merlino, and I. Pastan Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines Proc Natl Acad Sci U S A 81 23 Dec. 1984 7308 7312 (Pubitemid 15196172)